Malignant Post-Transplant Lymphoproliferative Disorder of Nasopharynx in Myelodysplastic Disorder.

PTLD hematogenic disorder lymphoma nasopharynx polymorphism

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
17 Feb 2021
Historique:
received: 07 12 2020
revised: 30 01 2021
accepted: 16 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 7 3 2021
Statut: epublish

Résumé

(1) Background: Post-transplant lymphoproliferative disorder (PTLD) is a hematological disease and occurs because of immunosuppression after organ transplantation. Only a few studies have reported PTLD in the nasopharynx. In most cases, PTLD developed after solid organ transplantation, and cases of PTLD after bone marrow transplantation, are uncommon. (2) Case presentation: We report the case of a 40-year-old woman with myelodysplastic disorder who underwent hematopoietic stem cell transplantation (HSCT). After 3 months, she developed low-grade fever, progressive nasal obstruction, and bloody rhinorrhea. Endoscopy revealed a mass completely occupying the nasopharynx. A polymorphic PTLD was diagnosed on the basis of histopathological examination results. Reduction in immunosuppression and low-dose radiotherapy were prescribed for treatment. After a 3-year follow-up, no recurrence of PTLD or myelodysplastic disorder was detected. (3) Conclusions: While nasopharyngeal PTLD is rare, a routine examination of the nasopharynx should be considered in the post-transplant follow-up of patients for early detection and treatment of PTLD.

Identifiants

pubmed: 33671238
pii: healthcare9020217
doi: 10.3390/healthcare9020217
pmc: PMC7922535
pii:
doi:

Types de publication

Case Reports

Langues

eng

Références

Int J Clin Exp Med. 2014 Jul 15;7(7):1904-9
pubmed: 25126199
B-ENT. 2011;7(1):61-4
pubmed: 21563560
Trends Immunol. 2014 Apr;35(4):159-69
pubmed: 24589417
Transpl Int. 2015 Nov;28(11):1299-307
pubmed: 26147593
Transplant Proc. 2010 Dec;42(10):4653-7
pubmed: 21168754
Am J Rhinol. 2002 Jan-Feb;16(1):37-42
pubmed: 11895192
Turk J Gastroenterol. 2018 May;29(3):354-360
pubmed: 29755021
Hum Pathol. 1995 May;26(5):525-30
pubmed: 7750936
Br J Haematol. 2010 Jun;149(5):675-92
pubmed: 20408847
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727

Auteurs

Chih-Wei Luan (CW)

Department of Otorhinolaryngology Head and Neck Surgery, Lo Sheng Sanatorium and Hospital Ministry of Health and Welfare, New Taipei City 242, Taiwan.
Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.

Chih-Cheng Chen (CC)

Division of Hematology and Oncology, Chang Gung Memorial Hospital, Chiayi Branch 613, Taiwan.

Kam-Fai Lee (KF)

Department of Pathology, Chang Gung Memorial Hospital, Chiayi Branch 613, Taiwan.

Ming-Shao Tsai (MS)

Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Department of Otolaryngology, Chang Gung Memorial Hospital, Chiayi Branch 613, Taiwan.
Faculty of Medicine, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.

Yao-Te Tsai (YT)

Department of Otolaryngology, Chang Gung Memorial Hospital, Chiayi Branch 613, Taiwan.

Cheng-Ming Hsu (CM)

Department of Otolaryngology, Chang Gung Memorial Hospital, Chiayi Branch 613, Taiwan.
Faculty of Medicine, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.

Geng-He Chang (GH)

Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Department of Otolaryngology, Chang Gung Memorial Hospital, Chiayi Branch 613, Taiwan.
Faculty of Medicine, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.

Classifications MeSH